Former Funding Officer of One of many World’s Largest Sovereign Wealth Funds Shares His Present Focus

January 26, 2023 ( Newswire) Streetwise Experiences sat down with Øyvind Schanke, the chief funding officer of TD Veen and the previous funding officer of one of many world’s largest sovereign wealth funds as he shares his present focus.

Whereas some funding corporations focus solely on the underside line, some have a a lot brighter aim in thoughts. And whereas cash continues to be vital to TD Veen, it isn’t the mission. As a substitute, TD Veen is a family-centered funding firm with one aim in thoughts: to speculate solely in that which advantages society. We at Streetwise Experiences have been intrigued by TD Veen’s premise, so we sat down with its chief funding officer Øyvind Schanke to study extra about TD Veen and the businesses it invests in.

Øyvind Schanke joined the corporate in 2020 after years of funding expertise. Earlier than working with TD, Veen Schanke spent virtually 16 years on the Norwegian Sovereign Wealth fund, one of many world’s largest sovereign wealth funds, the final years because the CIO for asset administration primarily based in London.

Foremost Funding Positions

The general public corporations TD Veen invests in are listed under.

You’ll be able to obtain a full record of their funding positions. Nevertheless, irrespective of the funding, TD Veen was based below the premise that individuals wanted to put money into social entrepreneurship, so the corporate retains a boutique record of corporations below its record, with a particular give attention to the well being and life science sectors, particularly psychological well being.

Why TD Invests in Psychological Well being

Whereas Schanke spoke positively about emergency care inside Norway’s public well being system, he identified an unbelievable want to extend the standard of preventative care in his nation.

He mentioned, “there is no such thing as a treatment, only a bandaid,” particularly relating to habit and different psychological well being problems.

Norway has an extremely excessive suicide charge per capita, with 10.9 suicides per 100,000. In actual fact, in response to The Borgen Venture, “about half of all individuals in Norway expertise a psychological well being dysfunction in some unspecified time in the future of their life,” and this has solely been exacerbated by Covid-19.

Not solely are Norwegians experiencing increased charges of psychological sickness because of Covid-19, however the lack of sunshine throughout the winter months could make issues quite a bit worse by including seasonal affective dysfunction on high of basic points.

Linda Geddes from The Atlantic gave an summary of this problem and spoke with these in Northern European international locations to get their private tackle how the dearth of sunshine in winter months impacts them right here.

The principle therapy for despair is at the moment remedy and antidepressants, which Norwegians take a variety of. Nevertheless, whereas antidepressants can calm the signs of despair, they do not go to the foundation of the issue. For this reason the crew at TD Veen noticed an overarching want for extra complete psychological well being care inside Norway and the world, in order that they put their cash the place their coronary heart is and started investing in it — actually.

Chart Supply: Dadaviz. Knowledge Supply: OECD.

TD Veen first constructed a relationship with Atai Life Sciences NV (ATAI:NASDAQ), a mental-health-focused bio-pharmaceutical firm headquartered in Berlin, Germany. This started in 2018, as Øyvind Schanke had a name with the corporate and determined he wanted to study extra in regards to the medicinal use of psychedelics in treating psychological well being problems. He then met with the corporate in Oslo, the place he was launched to Awakn Life Sciences Corp. (AWKN:NEO; AWKNF:OTCQB), a biopharma firm utilizing controversial medication to deal with alcohol use dysfunction and different addictions. Presently, Awakn is utilizing ketamin of their clinics, with 5 clinics in complete, two of that are in Norway. They’re additionally in the course of trials for MDMA.

Psychedelics a Burgeoning Market

Whereas the usage of psychedelics is a controversial follow, it’s gaining an increasing number of traction. Analysis and Markets predicted that the worldwide psychedelic medication market would attain US$10.75 billion by 2027. And this isn’t for leisure use however moderately for its capability to help in treating psychological sickness. A research from the Centre for Psychedelic Analysis at Imperial School London discovered that psilocybin, the energetic compound in magic mushrooms, may very well be simply as efficient as anti-depressants in a scientific setting.

In 2022, Netflix launched a docu-series on the waves psychedelics have been making within the bio-pharma world titled “Tips on how to Change Your Thoughts.”

The third episode of the sequence focuses closely on the historical past of MDMA, its results, and the way it may very well be used to deal with each PTSD and habit because the drug turns off the worry heart of the mind, permitting for a affected person and therapist to dig into deepest wounds with out ache or worry.

General, research have proven the optimistic results of MDMA on these sufferers, and this is among the causes TD Veen is now a proud investor in Awakn. Øyvind Schanke informed Streetwise Experiences, “We consider in combining the [MDMD] compound with remedy at Awakn, and that’s our perception that it must occur . . . I do know that is wanted.”

It appears many analysts agree with him. In July, H.C. Wainright & Co. Senior Healthcare Analyst Patrick Trucchio famous that “Awakn is advancing MDMA-assisted remedy for AUD in Europe, which we estimate might have blockbuster drug potential primarily based on the numerous unmet medical want and proof generated to-date pointing to the potential of MDMA-assisted remedy in a wide range of temper problems.”

Then in November, Maxim Fairness Analysis’s Jason McCarthy wrote, “Contemplating that personal habit therapy comes with a 70%-80% fail charge and therapy can value north of US$30K, the chance for Awakn to enhance this mannequin is critical.” He went on to say, “The unmet medical want and alternative for revolutionary approaches to therapy may be very excessive.”

Awakn at the moment has 5 essential clinics in Norway, and each the corporate and TD Veen hope this can proceed to increase.

What’s Subsequent?

Going ahead, TD Veen will proceed to put money into corporations that, of their eyes, enhance the world. They goal to generate sufficient funds in order that exits aren’t wanted as a result of the less exists, the higher. In 2022, TD Veen solely had 4 exits and invested in six new corporations. As Schanke mentioned, “We wish to be the world’s finest minority shareholder.”

TD Veen was based by Tor Dagfinn Veen in 1986. In line with the corporate, “In the present day, Tor Dagfinn and Tone Veen personal 28% of the shares, whereas daughters Camilla and Silje Veen personal 36% every.

TD Veen has US$250 million below administration, and they don’t at the moment take cash globally however give attention to their family-centered enterprise mannequin. They’re headquartered in Stavanger, Norway, and it doesn’t matter what they put money into, they’ll achieve this below their mantra: An funding is just good if it additionally advantages society.


1) Katherine DeGilio wrote this text for Streetwise Experiences LLC. She or members of her family personal securities of the next corporations talked about within the article: None. She or members of her family are paid by the next corporations talked about on this article: None.

2) The next corporations talked about on this article are billboard sponsors of Streetwise Experiences: Awakn Life Sciences Corp. Click on right here for vital disclosures about sponsor charges. As of the date of this text, an affiliate of Streetwise Experiences has a consulting relationship with: Awakn Life Sciences Corp. Please click on right here for extra data.

3) Statements and opinions expressed are the opinions of the creator and never of Streetwise Experiences or its officers. The creator is wholly chargeable for the validity of the statements. The creator was not paid by Streetwise Experiences for this text. Streetwise Experiences was not paid by the creator to publish or syndicate this text. Streetwise Experiences requires contributing authors to reveal any shareholdings in, or financial relationships with, corporations that they write about. Streetwise Experiences depends upon the authors to precisely present this data and Streetwise Experiences has no technique of verifying its accuracy.

4) This text doesn’t represent funding recommendation. Every reader is inspired to seek the advice of along with his or her particular person monetary skilled and any motion a reader takes because of data offered right here is his or her personal duty. By opening this web page, every reader accepts and agrees to Streetwise Experiences’ phrases of use and full authorized disclaimer. This text is just not a solicitation for funding. Streetwise Experiences doesn’t render basic or particular funding recommendation and the data on Streetwise Experiences shouldn’t be thought of a advice to purchase or promote any safety. Streetwise Experiences doesn’t endorse or suggest the enterprise, merchandise, providers or securities of any firm talked about on Streetwise Experiences.

5) Occasionally, Streetwise Experiences LLC and its administrators, officers, workers or members of their households, in addition to individuals interviewed for articles and interviews on the location, might have an extended or brief place in securities talked about. Administrators, officers, workers or members of their quick households are prohibited from making purchases and/or gross sales of these securities within the open market or in any other case from the time of the choice to publish an article till three enterprise days after the publication of the article. The foregoing prohibition doesn’t apply to articles that in substance solely restate beforehand printed firm releases. As of the date of this text, officers and/or workers of Streetwise Experiences LLC (together with members of their family) personal securities of Awakn Life Sciences Corp., an organization talked about on this article.

Extra Data: Newswire

This information is printed on the Newswire – a worldwide digital information supply for traders and enterprise leaders

Disclaimer/Disclosure: is a digital writer of third occasion sourced information, articles and fairness analysis in addition to creates authentic content material, together with video, interviews and articles. Unique content material created by investorideas is protected by copyright legal guidelines apart from syndication rights. Our web site doesn’t make suggestions for purchases or sale of shares, providers or merchandise. Nothing on our websites ought to be construed as a suggestion or solicitation to purchase or promote merchandise or securities. All investing entails threat and attainable losses. This web site is at the moment compensated for information publication and distribution, social media and advertising, content material creation and extra. Disclosure is posted for every compensated information launch, content material printed /created if required however in any other case the information was not compensated for and was printed for the only curiosity of our readers and followers. Contact administration and IR of every firm straight relating to particular questions.

Extra disclaimer data: Be taught extra about publishing your information launch and our different information providers on the newswire and

World traders should adhere to rules of every nation. Please learn privateness coverage:

Follow Us on StockTwits

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button